Jiahui Zhang - Search Results

Year	Number of Results
2005	1
2006	3
2007	2
2009	4
2010	1
2011	2
2012	6
2013	5
2014	4
2015	8
2016	20
2017	26
2018	38
2019	40
2020	65
2021	75
2022	118
2023	117
2024	53

1

Turning cold tumors hot: from molecular mechanisms to clinical applications.

Zhang J, Huang D, Saw PE, Song E. Zhang J, et al. Trends Immunol. 2022 Jul;43(7):523-545. doi: 10.1016/j.it.2022.04.010. Epub 2022 May 25. Trends Immunol. 2022. PMID: 35624021 Review.

2

Emerging roles of tRNA-derived fragments in cancer.

Fu M, Gu J, Wang M, Zhang J, Chen Y, Jiang P, Zhu T, Zhang X. Fu M, et al. Among authors: zhang j. Mol Cancer. 2023 Feb 13;22(1):30. doi: 10.1186/s12943-023-01739-5. Mol Cancer. 2023. PMID: 36782290 Free PMC article. Review.

3

Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides.

Huang D, Zhu X, Ye S, Zhang J, Liao J, Zhang N, Zeng X, Wang J, Yang B, Zhang Y, Lao L, Chen J, Xin M, Nie Y, Saw PE, Su S, Song E. Huang D, et al. Among authors: zhang j. Nature. 2024 Jan;625(7995):593-602. doi: 10.1038/s41586-023-06834-7. Epub 2023 Dec 13. Nature. 2024. PMID: 38093017

4

Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design.

Wang Y, Wang J, Zheng W, Zhang J, Wang J, Jin T, Tao P, Wang Y, Liu C, Huang J, Lee PY, Yu X, Zhou Q. Wang Y, et al. Among authors: zhang j. Immunity. 2023 Jul 11;56(7):1485-1501.e7. doi: 10.1016/j.immuni.2023.05.014. Epub 2023 Jun 13. Immunity. 2023. PMID: 37315560

5

Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy.

Zhang J, Ji C, Zhang H, Shi H, Mao F, Qian H, Xu W, Wang D, Pan J, Fang X, Santos HA, Zhang X. Zhang J, et al. Sci Adv. 2022 Jan 14;8(2):eabj8207. doi: 10.1126/sciadv.abj8207. Epub 2022 Jan 12. Sci Adv. 2022. PMID: 35020437 Free PMC article.

6

LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling.

Yang Q, Wang M, Xu J, Yu D, Li Y, Chen Y, Zhang X, Zhang J, Gu J, Zhang X. Yang Q, et al. Among authors: zhang j. Mol Cancer. 2023 Aug 4;22(1):122. doi: 10.1186/s12943-023-01814-x. Mol Cancer. 2023. PMID: 37537569 Free PMC article.

7

Clinical Implications of a New DDX58 Pathogenic Variant That Causes Lupus Nephritis due to RIG-I Hyperactivation.

Peng J, Wang Y, Han X, Zhang C, Chen X, Jin Y, Yang Z, An Y, Zhang J, Liu Z, Chen Y, Gao E, Zhang Y, Xu F, Zheng C, Zhou Q, Liu Z. Peng J, et al. Among authors: zhang j. J Am Soc Nephrol. 2023 Feb 1;34(2):258-272. doi: 10.1681/ASN.2022040477. Epub 2022 Oct 19. J Am Soc Nephrol. 2023. PMID: 36261300 Free PMC article.

8

Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.

Zhang J, Li Y, Liu H, Zhang J, Wang J, Xia J, Zhang Y, Yu X, Ma J, Huang M, Wang J, Wang L, Li Q, Cui R, Yang W, Xu Y, Feng W. Zhang J, et al. J Exp Clin Cancer Res. 2022 Jan 15;41(1):24. doi: 10.1186/s13046-022-02242-3. J Exp Clin Cancer Res. 2022. PMID: 35033172 Free PMC article.

9

How to Build a Fire: The Genetics of Autoinflammatory Diseases.

Zhang J, Lee PY, Aksentijevich I, Zhou Q. Zhang J, et al. Annu Rev Genet. 2023 Nov 27;57:245-274. doi: 10.1146/annurev-genet-030123-084224. Epub 2023 Aug 10. Annu Rev Genet. 2023. PMID: 37562411 Free article. Review.

10

Dual-target inhibitors of PARP1 in cancer therapy: A drug discovery perspective.

Zhang J, Zhang J, Li H, Chen L, Yao D. Zhang J, et al. Drug Discov Today. 2023 Jul;28(7):103607. doi: 10.1016/j.drudis.2023.103607. Epub 2023 May 3. Drug Discov Today. 2023. PMID: 37146962 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

515 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

515 results

Results by year